Several genes within this pathway have been reported to show association with ovarian cancer, including Cyclin D1 (CCND1), CDK2, ERB2, and EGFR. The cyclins function as regulators of Cyclin-dependent kinases (CDKs) and play an important role in the cell cycle G1/S transition. Here, CDK2 is linked to ovarian carcinoma.